Industry Insights
Anthropic’s One-Person Biotech Is a Warning Shot
Anthropic’s Mithril deal hints at a biotech shift: AI may shrink the team needed to launch a drug program. But mouse results are not medicine—and compute alone won’t close that gap.
Read article→